Pipeline

Proprietary Pipeline

Through its tetravalent bispecific antibody (mAb²™) format, F-star is generating a rich proprietary pipeline of first- and best-in-class drug candidates with monoclonal antibody-like manufacturability.

Partners
  • FStar
  • Undisclosed IO programmes
  • FStar
  • CNS products based on Fcabs against TfR and undisclosed targets
  • FStar
  • Immuno-regulatory mAb2 products